The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Edwards Lifesciences Corp

NYSE: EW
Last

(U.S.) $115.87

Today's change-1.27 -1.08%
Updated July 25 4:02 PM EDT. Delayed by at least 15 minutes.
 

Edwards Lifesciences Corp

NYSE: EW
Last

(U.S.) $115.87

Today's change-1.27 -1.08%
Updated July 25 4:02 PM EDT. Delayed by at least 15 minutes.

Edwards Lifesciences Corp crosses below 50-day moving average

Edwards Lifesciences Corp closed lower Tuesday, dropping (U.S.)$1.27 or 1.08% to (U.S.)$115.87 and crossing below its 50-day moving average. Shares have lost 0.53% over the last five days, but sit 4.83% below their 52-week high. This security has underperformed the S&P 500 by 5.46% during the last year.

Key company metrics

  • Open(U.S.) $117.64
  • Previous close(U.S.) $117.14
  • High(U.S.) $117.64
  • Low(U.S.) $115.00
  • Bid / Ask(U.S.) $112.57 / (U.S.) $115.90
  • YTD % change+23.66%
  • Volume1,537,779
  • Average volume (10-day)1,134,811
  • Average volume (1-month)1,110,932
  • Average volume (3-month)1,381,774
  • 52-week range(U.S.) $81.12 to (U.S.) $121.75
  • Beta0.64
  • Trailing P/E38.35×
  • P/E 1 year forward33.18×
  • Forward PEG2.12×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.02
Updated July 25 4:02 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.49%Sector:HealthcareIndustry:Advanced Medical Equipment

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue884768739759
Total other revenue--------
Total revenue884768739759
Gross profit668555538557
Total cost of revenue216213201203
Total operating expense590567554590
Selling / general / administrative230234230229
Research & development129115113113
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)105744
Other operating expenses, total-4139
Operating income294200185169
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax294200185169
Income after tax230159141127
Income tax, total63424442
Net income230159141127
Total adjustments to net income--------
Net income before extra. items230159141127
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items230159141127
Inc. avail. to common incl. extra. items230159141127
Diluted net income230159141127
Dilution adjustment----0--
Diluted weighted average shares216218218217
Diluted EPS excluding extraordinary itemsvalue per share1.060.730.650.58
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share1.100.740.670.73